75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY

BACKGROUND: Programmed death receptor ligand one (PD-L1) expression is known to predict response to PD-1/PD-L1 inhibitors in non-small cell lung cancer (NSCLC). However, the predictive role of this biomarker in brain metastases (BMs) is unknown. The aim of this study was to assess whether PD-L1 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulsbergen, Alexander, Mammi, Marco, Nagtegaal, Steven, Malk, Asad, Kavouridis, Vasileios, Smith, Timothy, Iorgulescu, Bryan, Mekary, Rania, Verhoeff, Joost, Broekman, Marike, Phillips, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401370/
http://dx.doi.org/10.1093/noajnl/vdaa073.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401370/
http://dx.doi.org/10.1093/noajnl/vdaa073.062

Ejemplares similares